Pharmacological Properties of Bacterial Bioactive Molecules

The pure or standardized extracts obtained from microbes like bacteria, fungi, actinomycetes, etc. are considered important sources of bioactive compounds. Some of the microbes show inhibitory action against the growth of certain bacteria, fungi, yeast, insects, etc. This provides opportunities for the development of newer drugs and enzymes or beneficial compounds. Large number of bacteria are responsible for producing different bioactive compounds like antibiotics, enzymes, and other secondary metabolites. Some compounds like Gallic acid, Amicoumacin, Prodigiosin, Nystatin, Spinosad, Milbemycin, Lipstatin, Subtilin, Albaflavenone, and Mollemycin A have been studied for their affectivity against bacterial, fungal, insects, pests, etc. These compounds are gaining increasing interest because of their unique composition and the possibility of wide industrial applications.